scholarly journals Latent Abnormal Pathology Affects Long-Term Graft Function in Elder Living Renal Allograft Recipients

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Linlin Ma ◽  
Lei Zhang ◽  
Yu Du ◽  
Zelin Xie ◽  
Yawang Tang ◽  
...  

Objective. This study evaluated the long-term effects and clinical significance of latent abnormal pathology on elder living donor kidney graft function after renal transplantation in China. Methods. One-hundred and thirty-eight living donor renal transplantations have been carried out at our hospital in recent years. Of these, 72 Time-Zero biopsies were performed and used in this analysis. Clinical data were retrospectively measured at 3, 6, 12, and 24 months after renal transplants. Relationships and effects from biopsy results taken from implanted donor kidney grafts were analyzed. Results. Time-Zero biopsy pathology results from donor kidneys showed that 48.61% of donor kidneys had latent abnormal changes; arterial lesions of donor kidneys had significant effects on the renal function of grafts after 2 years' transplantation; correlations between donor age and arterial lesions were significant; and Time-Zero biopsy pathology results could help predict the long-term function of a renal graft. Conclusions. Existing latent pathological changes of an elder living donor kidney before transplantation could affect long-term renal function. Whether a senior donor is used should be very carefully considered.

2009 ◽  
Vol 23 (4) ◽  
pp. 437-446 ◽  
Author(s):  
Francois Kleinclauss ◽  
Martin Fauda ◽  
David E.R. Sutherland ◽  
Colette Kleinclauss ◽  
Rainer W. Gruessner ◽  
...  

2021 ◽  
pp. 1-11
Author(s):  
Massimo Torreggiani ◽  
Ciro Esposito ◽  
Elena Martinelli ◽  
Thomas Jouve ◽  
Antoine Chatrenet ◽  
...  

<b><i>Introduction:</i></b> Living donor kidney transplant (LDKT) is one of the best therapeutic options for end-stage kidney disease (ESKD). Guidelines identify different estimated glomerular filtration rate (eGFR) thresholds to determine the eligibility of donors. The aim of our study was to evaluate whether pretransplant donor eGFR was associated with kidney function in the recipient. <b><i>Methods:</i></b> We retrospectively studied LDKT recipients who received a kidney graft between September 1, 2005, and June 30, 2016 in the same transplant center in France and that had eGFR data available at 3, 12, 24, and 36 months posttransplant. <b><i>Results:</i></b> We studied 90 donor-recipient pairs. The average age at time of transplant was 51.47 ± 10.95 for donors and 43.04 ± 13.52 years for recipients. Donors’ average eGFR was 91.99 ± 15.37 mL/min/1.73 m<sup>2</sup>. Donor’s age and eGFR were significantly correlated (<i>p</i> &#x3c; 0.0001, <i>r</i><sup>2</sup> 0.023). Donor’s age and eGFR significantly correlated with recipient’s eGFR at 3, 12, and 24 months posttransplant (age: <i>p</i> &#x3c; 0.001 at all intervals; eGFR <i>p</i> = 0.001, 0.003, and 0.016, respectively); at 36 months, only donor’s age significantly correlated with recipient’s eGFR. BMI, gender match, and year of kidney transplant did not correlate with graft function. In the multivariable analyses, donor’s eGFR and donor’s age were found to be associated with graft function; correlation with eGFR was lost at 36 months; and donor’s age retained a strong correlation with graft function at all intervals (<i>p</i> &#x3c; 0.001). <b><i>Conclusions:</i></b> Donor’s eGFR and age are strong predictors of recipient’s kidney function at 3 years. We suggest that donor’s eGFR should be clinically balanced with other determinants of kidney function and in particular with age.


2006 ◽  
Vol 82 (5) ◽  
pp. 651-656 ◽  
Author(s):  
Todd V. Brennan ◽  
Alan Bostrom ◽  
Sandy Feng

2012 ◽  
Vol 31 (4) ◽  
pp. 901-906 ◽  
Author(s):  
J. Hellegering ◽  
J. Visser ◽  
H. J. Kloke ◽  
F. C. H. D’Ancona ◽  
A. J. Hoitsma ◽  
...  

2012 ◽  
Vol 94 (10S) ◽  
pp. 1094
Author(s):  
D. J. Joo ◽  
H. S. Lee ◽  
K. H. Huh ◽  
M. K. Ju ◽  
M. S. Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document